World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
32457
World Ranking
14453
National Ranking
7308

Overview

Philip J. Clements is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on medicine, with significant contributions in pathology and forensic medicine, pulmonary and respiratory medicine, epidemiology, physiology, and speech and hearing.

The scientist has published extensively on topics related to systemic sclerosis and related diseases, interstitial lung diseases and idiopathic pulmonary fibrosis, inflammatory myopathies and dermatomyositis, salivary gland disorders and functions, dysphagia assessment and management, workaholism, burnout, and well-being, as well as mast cells and histamine.

Recent publications include:

  • Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II (2020, ACR Open Rheumatology)
  • Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease (2020, Arthritis & Rheumatology)
  • Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts (2022, ACR Open Rheumatology)
  • Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II (2020, ACR Open Rheumatology)
  • Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis (2020, European Medical Journal)

Frequent co-authors of Philip J. Clements include Elizabeth R. Volkmann, Daniel E. Furst, Dinesh Khanna, Donald P. Tashkin, and Michael D. Roth.

The scientist's work often appears in several publication venues, notably:

  • ACR Open Rheumatology
  • Journal of Scleroderma and Related Disorders
  • Arthritis & Rheumatology
  • European Medical Journal
  • Seminars in Arthritis and Rheumatism

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    O. Kowal-Bielecka;R. Landewé;J. Avouac;S. Chwiesko

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Yannick Allanore

  • Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study

    Fredrick M. Wigley;Robert A. Wise;James R. Seibold;Deborah A. McCloskey

  • High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

    Philip J. Clements;Daniel E. Furst;Weng Kee Wong;Maureen Mayes

  • Human lymphocyte subpopulations. Effect of corticosteroids.

    D T Yu;P J Clements;H E Paulus;J B Peter

  • The Modified Rodnan Skin Score Is an Accurate Reflection of Skin Biopsy Thickness in Systemic Sclerosis

    Daniel E. Furst;Philip J. Clements;Philip J. Clements;Virginia D. Steen;Virginia D. Steen;Thomas A. Medsger;Thomas A. Medsger

  • Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic Arthritis

    Robert F. Willkens;H. James Williams;John R. Ward;Marlene J. Egger

  • Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

    Ronald G. Ungerer;Donald P. Tashkin;Daniel Furst;Philip J. Clements

  • Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High‐dose versus low‐dose penicillamine trial

    Philip J. Clements;Eric L. Hurwitz;Weng Kee Wong;James R. Seibold

  • Does God Determine Your Health? The God Locus of Health Control Scale

    Kenneth A. Wallston;Vanessa L. Malcarne;Lise Flores;Ingunn Hansdottir

  • Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

    Paul J. DeMarco;Michael H. Weisman;James R. Seibold;Daniel E. Furst

  • Skin score: A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis

    Philip J. Clements;Peter A. Lachenbruch;Swee Cheng Ng;Michael Simmons

  • High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

    Jonathan G. Goldin;David A. Lynch;Diane C. Strollo;Robert D. Suh

  • Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

    Dinesh Khanna;Ron D. Hays;Ron D. Hays;Paul Maranian;James R. Seibold

  • Systemic sclerosis: hypothesis-driven treatment strategies.

    Christina Charles;Philip Clements;Daniel E Furst

Frequent Co-Authors

Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Donald P. Tashkin
Donald P. Tashkin University of California, Los Angeles
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Virginia D. Steen
Virginia D. Steen Georgetown University
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Jonathan G. Goldin
Jonathan G. Goldin University of California, Los Angeles
John Varga
John Varga University of Michigan–Ann Arbor
Michael H. Weisman
Michael H. Weisman Cedars-Sinai Medical Center
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in a healthcare career, but not sure if traditional medical school is the right path? There are numerous related online degrees and flexible career pathways in the U.S. nursing and healthcare fields.

For working nurses, advancing your education can be more affordable and accessible. Consider programs like the cheapest rn to bsn program, designed for registered nurses seeking to earn a Bachelor of Science in Nursing online at a lower cost. Those aiming for the highest academic qualifications may look into an online phd nursing, which can open doors in research, academia, or leadership roles.

Not currently a nurse but want to switch careers quickly? Direct entry msn programs allow individuals with a non-nursing bachelor’s degree to earn a Master of Science in Nursing on an accelerated timeline. Alternatively, if you’re looking for accessible programs, check out direct entry nursing programs with more flexible admissions.

These online degrees and pathways offer a range of entry points into fulfilling healthcare careers, whether you’re starting out or advancing your current qualifications.

Best Scientists Citing Philip J. Clements

Trending Scientists

Recently Published Articles